Managing Diabetes

2012
ISBN: 978-1-908517-57-9
Verlag: Springer Healthcare Ltd.

Buch, Englisch, 125 Seiten, Paperback, Format (B × H): 142 mm x 216 mm, Gewicht: 184 g

Managing Diabetes is a up-to-date, comprehensive showcase of the current pharmaceutical trends in treating diabetes and provides a unbiased, inclusive discussion of current and emerging treatments by well-known experts in the field.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Evans, Marc

Vora, Jiten

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Diabetologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie

Inhaltsverzeichnis

Introduction.- Management strategies for diabetes.- Insulin therapies.- Non-insulin agents for diabetes.- New and future therapies.- Managing the complications of diabetes.

Über Autor(innen)

Marc Evans has been a consultant diabetologist at Llandough Hospital and the University Hospital of Wales since the beginning of 2003. He was previously a lecturer in diabetes and endocrinology at the University of Wales College of Medicine. Dr Evans has multiple ongoing academic and clinical interests, including the health economics of diabetes care and health outcomes in people with type 2 diabetes. He has published over 200 articles, book chapters and abstracts and is currently Editor-in-Chief of Diabetes Therapy. Jiten Vora is a consultant physician and honorary professor at the Royal Liverpool University Hospital and the University of Liverpool. He qualified from the University of Cambridge and undertook substantive training in diabetes and endocrinology as a research fellow and then lecturer at the University of Wales College of Medicine. He then undertook a period as a Fulbright senior fellow at Oregon Health Sciences University. He has been a consultant physician and endocrinologist at the Royal Liverpool University Hospital since 1993. He has served on many advisory panels including the National Institute for Clinical Excellence (NICE) and the Diabetes and Renal National Service Frameworks. He has been actively involved in the district-wide delivery of diabetes care. Professor Vora has ongoing research interests in the development, screening, and treatment of diabetic retinopathy, renal hemodynamics and function, hypertension in type 2 diabetes, renal disease prevention, and the physiological aspects of type 2 diabetes treatment. He has published extensively in these fields.